This report investigates the ancient Hebrew and Greek vocabulary associated with evil, adversity, demons, spirits, worship, praise, truth and moral judgement. It examines the original meanings of these terms, their historical development and their significance within biblical literature and the wider human experience. The investigation begins with the Hebrew word raʿ and the Greek adjective ponērós. Both possess a broad semantic range encompassing undesirable conditions, hardship, distress, harmful circumstances and moral wrongdoing. Biblical passages from Genesis and Ecclesiastes demonstrate that language translated as evil can describe difficult human experiences without necessarily identifying moral wickedness. The report subsequently examines the historical development of Greek daímōn and daimónion, Hebrew terminology associated with spirits and adversaries, and Greek diábolos, meaning slanderer or accuser. It considers how these expressions developed within Jewish and Christian traditions and why their ancient meanings should not automatically be equated with modern English translations. The linguistic investigation provides a foundation for examining human needs, personal interests, circumstances, character and moral responsibility. Biblical teachings concerning honest weights and measures, truthful speech, slander and false accusation are considered alongside the vocabulary of worship, praise and glory. The final sections investigate the Greek Logos in John's Gospel, the biblical understanding of flesh, human biological existence, moral limitation and the Christian theology of Christ and grace. The central argument is that ancient terminology translated as evil must be understood within its original linguistic, historical and literary contexts before moral or theological conclusions are drawn. This distinction also provides a framework for investigating how human beings experience good and bad, distinguish personal advantage from justice, and evaluate their own conduct and the conduct of others.
No takes yet. Share an insight, caveat, or question.
Scott Osborn (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: